The India pharmaceutical contract sales organizations market size is anticipated to reach USD 588.7 million by 2030. The market is projected to grow at a CAGR of 12.5% from 2025 to 2030. The growing pharmaceutical industry, pharmaceutical product approval, and commercialization are the major factors contributing to the market growth. As per the Indian Ministry of Health and Family Welfare, in 2022, the pharmaceutical sector in India comprised 3,000 drug companies and 10,500 manufacturing units.
The increasing outsourcing trends in the Indian pharmaceutical industry has propelled market expansion. Many companies use outsourcing research to India, appealing due to its advantages and benefits. The competitive pricing of services in India enables significant cost reduction for companies, providing them access to the market. A rising trend involves incorporating technology into outsourcing. Technological advancements like artificial intelligence, machine learning, and automation are reshaping the pharmaceutical industry, with CSOs leveraging these advancements to enhance their services.
Furthermore, strong government support and rising pharmaceutical R&D spending is expected to drive the market growth. For instance, in April 2023, the Indian government planned to enhance research and innovation in India's pharmaceuticals and medical technology sectors through a five-year program with a budget of USD 599.99 million. This development holds significance as research and development (R&D) constitute only 7% of the overall expenditure in the Indian pharmaceutical industry, in contrast to the over 35% observed in developed countries.
This product will be delivered within 2 business days.
The increasing outsourcing trends in the Indian pharmaceutical industry has propelled market expansion. Many companies use outsourcing research to India, appealing due to its advantages and benefits. The competitive pricing of services in India enables significant cost reduction for companies, providing them access to the market. A rising trend involves incorporating technology into outsourcing. Technological advancements like artificial intelligence, machine learning, and automation are reshaping the pharmaceutical industry, with CSOs leveraging these advancements to enhance their services.
Furthermore, strong government support and rising pharmaceutical R&D spending is expected to drive the market growth. For instance, in April 2023, the Indian government planned to enhance research and innovation in India's pharmaceuticals and medical technology sectors through a five-year program with a budget of USD 599.99 million. This development holds significance as research and development (R&D) constitute only 7% of the overall expenditure in the Indian pharmaceutical industry, in contrast to the over 35% observed in developed countries.
India Pharmaceutical Contract Sales Organizations Market Report Highlights
- In terms of service, the non-personal promotion segment dominated the service segment with more than 56.0% share in 2024 owing to its efficiency and cost-effectiveness
- The personal promotion segment is also expected to show a significant share in the market. This is attributed to complex products and services
- In terms of end-use, the pharmaceutical companies segment held the largest market share in 2024. The increase in the number of new small molecule drug launches is anticipated to be a major driving factor for the market growth
- The biopharmaceutical companies’ segment is expected to grow at the fastest CAGR over the forecast period
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This Report Addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. India Pharmaceutical Contract Sales Organizations Market Variables, Trends, & Scope
Chapter 4. India Pharmaceutical Contract Sales Organizations Market: Service Business Analysis
Chapter 5. India Pharmaceutical Contract Sales Organizations Market: Therapeutic Areas Business Analysis
Chapter 6. India Pharmaceutical Contract Sales Organizations Market: End Use Business Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- CMIC Holdings Co., Ltd.
- Axxelus
- EPS Corporation
- QFR Solutions
- MaBico
- Mednext Pharma Pvt. Ltd.
- Peak Pharma Solutions Inc.
- IQVIA Inc.
- Promoveo Health
- Syneous Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | March 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 292.9 Million |
| Forecasted Market Value ( USD | $ 588.7 Million |
| Compound Annual Growth Rate | 12.5% |
| Regions Covered | India |
| No. of Companies Mentioned | 10 |
